Date | Time | Source | Announcement |
---|---|---|---|
23 Feb 2007 | 03:16 PM | Holding(s) in Company | |
13 Feb 2007 | 04:40 PM | Notice of Results | |
12 Dec 2006 | 11:55 AM | Total Voting Rights | |
30 Nov 2006 | 03:18 PM | Director/PDMR Shareholding | |
15 Nov 2006 | 03:41 PM | Result of AGM | |
15 Nov 2006 | 07:00 AM | Licenses novel Peptide | |
08 Nov 2006 | 11:11 AM | Holding(s) in Company | |
08 Nov 2006 | 10:21 AM | Director/PDMR Shareholding | |
18 Sep 2006 | 07:00 AM | Final Results | |
01 Sep 2006 | 07:00 AM | Notice of Results | |
14 Aug 2006 | 07:00 AM | Licensing Agreement | |
24 May 2006 | 07:00 AM | Research Update | |
11 Apr 2006 | 12:55 PM | Directorate Change | |
23 Feb 2006 | 07:00 AM | Interim Results | |
16 Jan 2006 | 11:00 AM | Notice of Results | |
16 Nov 2005 | 03:40 PM | Director/PDMR Shareholding | |
15 Nov 2005 | 12:15 PM | Result of AGM | |
15 Nov 2005 | 07:00 AM | Interferon-Beta Enters Clinic | |
14 Nov 2005 | 07:00 AM | Change of Adviser | |
27 Sep 2005 | 07:00 AM | Final Results | |
06 Sep 2005 | 09:00 AM | Notice of Results | |
13 Jul 2005 | 11:18 AM | Holding(s) in Company | |
22 Mar 2005 | 07:35 AM | Published Research | |
22 Mar 2005 | 07:00 AM | Published Research | |
18 Mar 2005 | 11:43 AM | Holding(s) in Company | |
09 Mar 2005 | 07:00 AM | Collaboration with Centocor | |
09 Mar 2005 | 07:00 AM | Interim Results | |
28 Feb 2005 | 12:00 PM | Notice of Results | |
04 Nov 2004 | 09:27 AM | Holding(s) in Company |
Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic.
Synairgen is a specialist respiratory biotech company whose primary focus is developing our investigative inhaled interferon beta candidate (SNG001) for severe viral lung infections.
Synairgen share price launched at 155p in 2004.